Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib

par M. I. Sekacheva, R. I. Nuriev, A. A. Rozhkov, A. V. Semenkov, N. N. Bagmet, A. M. Boroda
Publié 2020

Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: trea...

par Ieni A, Barresi V, Ricciardi GRR, Adamo B, Adamo V, Tuccari G
Publié 2016

Optimizing sgRNA to Improve CRISPR/Cas9 Knockout Efficiency: Special Focus on Human and Animal Cell

par Sadegh Shojaei Baghini, Zhanna R. Gardanova, Zhanna R. Gardanova, Angelina Olegovna Zekiy, Navid Shomali, Foad Tosan, Mostafa Jarahian
Publié 2021

Molecular Analysis of Elements of Melanoma Insensitivity to TCR-Engineered Adoptive Cell Therapy

par Ali R. Jazirehi
Publié 2021

Dual Hyaluronic Acid and Folic Acid Targeting pH-Sensitive Multifunctional 2DG@DCA@MgO-Nano-Core–Shell-Radiosensitizer for Breast Cancer Therapy

par Mostafa A. Askar, Noura M. Thabet, Gharieb S. El-Sayyad, Ahmed I. El-Batal, Mohamed Abd Elkodous, Omama E. El Shawi, Hamed Helal, Mohamed K. Abdel-Rafei
Publié 2021

Genetic Landscape and Emerging Therapies in Uveal Melanoma

par Rino S. Seedor, Marlana Orloff, Takami Sato
Publié 2021

High-throughput ex vivo drug testing identifies potential drugs and drug combinations for NRAS-positive malignant melanoma

par Laura Kohtamäki, Mariliina Arjama, Siru Mäkelä, Philipp Ianevski, Katja Välimäki, Susanna Juteau, Suvi Ilmonen, Daniela Ungureanu, Olli Kallioniemi, Astrid Murumägi, Micaela Hernberg
Publié 2022

Single-Cell Sequencing: Biological Insight and Potential Clinical Implications in Pediatric Leukemia

par Donát Alpár, Bálint Egyed, Csaba Bödör, Gábor T. Kovács
Publié 2021

Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations

par Whitney E. Lewis, PharmD, Lingzhi Hong, MD, PhD, Frank E. Mott, MD, George Simon, MD, Carol C. Wu, MD, Waree Rinsurongkawong, MS, MS, PhD, J. Jack Lee, MS, PhD, Vincent K. Lam, MD, John V. Heymach, MD, PhD, Jianjun Zhang, MD, PhD, Xiuning Le, MD, PhD
Publié 2021

ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution

par Irina V. Poddubnaya, Lyubov S. Al-Radi, Tatyana E. Byalik, Kamil D. Kaplanov, Valentina Z. Molostvova, Evgeniy A. Nikitin, Tatyana I. Pospelova, Vadim V. Ptushkin, Olga S. Samoilova, Elena A. Stadnik, Gayane S. Tumyan
Publié 2020

EGFR T790M: revealing the secrets of a gatekeeper

par Ko B, Paucar D, Halmos B
Publié 2017

Persistent Response to a Combination Treatment Featuring a Targeted Agent and an Immune Checkpoint Inhibitor in a Patient With Collecting Duct Renal Carcinoma: A Case Report and Li...

par Weimin Zhou, Ji Huang, Qiuming He, Qingfeng Luo, Xiaofang Zhang, Xuewei Tao, Hanzhi Dong, Xinhua Tu
Publié 2021

Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer

par Gongmin Zhu, Lijiao Pei, Hongwei Xia, Qiulin Tang, Feng Bi
Publié 2021

Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure?

par Raj Kumar Mongre, Chandra Bhushan Mishra, Arvind Kumar Shukla, Amresh Prakash, Samil Jung, Md Ashraf-Uz-Zaman, Myeong-Sok Lee
Publié 2021

Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities

par Sana Javaid, Talha Farooq, Zohabia Rehman, Ammara Afzal, Waseem Ashraf, Muhammad Fawad Rasool, Faleh Alqahtani, Sary Alsanea, Fawaz Alasmari, Mohammed Mufadhe Alanazi, Metab Alharbi, Imran Imran
Publié 2021

Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases

par Manzar Alam, Sabeeha Ali, Sarfraz Ahmed, Abdelbaset Mohamed Elasbali, Mohd Adnan, Asimul Islam, Md. Imtaiyaz Hassan, Dharmendra Kumar Yadav
Publié 2021

Adjuvant targeted therapy for non-small cell lung cancer

par Konstantin K. Laktionov, Aleksei M. Kazakov, Marat G. Gordiev, Pavel V. Kononets, Bakhrom B. Akhmedov, Julia N. Maevskaia
Publié 2020

Novel Therapies for Metastatic Non-Small Cell Lung Cancer with MET Exon 14 Alterations: A Spotlight on Capmatinib

par Tan AC, Loh TJ, Kwang XL, Tan GS, Lim KH, Tan DSW
Publié 2021

Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes

par Tseng YY, Yang TC, Wang YC, Lee WH, Chang TM, Kau YC, Liu SJ
Publié 2017

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity

par Dou XQ, Wang H, Zhang J, Wang F, Xu GL, Xu CC, Xu HH, Xiang SS, Fu J, Song HF
Publié 2018